Synulox R.T.U. - 100ml

CATTLE: Respiratory bacterial infections, soft tissue infections, metritis and mastitis. Withdrawel: MEAT AND OFFAL: 42 days, MILK: 80 hours PIGS: Respiratory bacterial infections in growing pigs, Colibacillosis and periparturient infections in sows. Withdrawal: MEAT AND OFFAL:31 days. DOG AND CATS: Respiratory tract infections, urinary tract infections and skin and soft tissue infections. Dosage: 1ml/20kg intramuscular or subcutaneous injection daily for 3-5 days. Active ingredient: Amoxicillin, Clavulanic

PMSG is capable of supplementing and being substituted for both luteinising hormone and follicle stimulating gonadotrophin of the anterior pituitary gland in both the male and female, stimulating development of the ovarian follicle. Dosage & Administration Make up immediately before use. • Reconstitute by dissolving the powder plug in about 5 ml of the solvent provided and then syringe the resulting solution into the solvent vial to mix with the remaining solvent. • Administer by subcutaneous or intramuscular injection using normal aseptic precautions. Cow • In conjunction with the use of progestagen treatment when used for oestrus control in non-cycling cattle: 400-700 iu Superovulation: 1500-4000 iu - on day 9-13 of oestrous cycle. Sow • Anoestrus post weaning (induction of oestrus is difficult until 40 days post partum): 1000 iu - s.c. or i.m. Fertile oestrus usually follows in 3 - 7 days. Ewe • In conjunction with progestagen-releasing sponges when used out of the normal breeding season: 500 iu - s.c. or i.m. at time of sponge removal. Withdrawals: Zero days

For the active immunisation of cattle against • Parainfluenza3 virus (PI3 virus), to reduce infections. • Bovine Respiratory Syncytial Virus (BRSV) to reduce infection and clinical signs. • Mannheimia (Pasteurella) haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6. Cross-reactive immunity to the A6 serotype of M. haemolytica has been demonstrated in a challenge experiment under laboratory conditions after a primary course of vaccination. Approximately two weeks after completion of the basic immunisation programme, the humoral immune response against BRS-Virus and PI3-Virus is at its highest level. The duration of protective immunity has not been established in challenge experiments. Dosage & Administration: Vaccination dose: 5 ml by subcutaneous injection at the side of the neck.

Thermometer with digital display. Reads in celsius degrees. Audible tone when constant temperature reached.